Dr. Reddy's, Glaxo Settle Imitrex Patent Dispute
Dr. Reddy's Laboratories has reached a patent litigation settlement with GlaxoSmithKline PLC and gained permission to sell a generic version of popular anti-headache drug Imitrex in the United States....To view the full article, register now.
Already a subscriber? Click here to view full article